Ignite Creation Date:
2024-07-17 @ 12:07 PM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06496048
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-11
First Post:
2024-07-03
Brief Title:
Lurbinectedin or in Combination With Irinotecan Versus Topotecan in Patients With Relapsed SCLC
Sponsor:
Organization:
Luye Pharma Group Ltd